Hereditary Cancer Panel (Standard)
Hereditary Cancer Panel testing analyzes DNA to identify genetic changes that may be associated with an increased risk of developing certain inherited cancers. This package covers 90 genes included in the standard test panel.
Examination List
- Encode Hereditary Multi-Cancer Panel
- Doctor’s Fee, Nursing and Hospital Services Fee
What can you learn from the test?
The results may identify genetic changes associated with an increased risk of certain cancers. Depending on the findings, the results may be classified as:
- Pathogenic or likely pathogenic variant detected: May indicate an increased inherited cancer risk and help guide appropriate screening, risk assessment, and specialist consultation.
- No clinically significant variant identified: Does not eliminate cancer risk, as cancer may result from other genetic, environmental, or lifestyle factors, and some genetic changes may not be detectable by the test.
- Variant of Uncertain Significance (VUS): A genetic change whose clinical significance is not yet established. Medical interpretation is required, and a VUS alone should not guide major medical or preventive surgical decisions.
Benefits of Testing
- Helps assess inherited cancer risk based on the genes included in the panel.
- Supports personalized cancer screening and follow-up planning.
- Provides information to support preventive healthcare planning.
- May help guide genetic counseling and risk assessment for family members when appropriate.
Who should consider this test?
This test is suitable for both men and women, particularly individuals with a personal or family history of cancer, multiple relatives affected by cancer, cancer diagnosed at an unusually young age in the family, or a suspected hereditary cancer syndrome.
Individuals do not need to have symptoms to consider genetic risk assessment. Testing may be appropriate for people who are currently healthy, depending on their personal and family history and clinical assessment.
Why is it important?
Understanding inherited cancer risk may help individuals and their healthcare providers develop a more appropriate screening and follow-up plan. However, this test assesses genetic risk; it does not diagnose cancer and cannot detect every possible genetic cause of cancer.
Important Information
Pre-test counseling is recommended to discuss the scope of testing, potential benefits and limitations, possible implications for family members, genetic data privacy, and associated costs. Results should be interpreted by an appropriately qualified healthcare professional in conjunction with personal and family medical history.
Preparation Before the Service
- Prepare your personal and family medical history, particularly cancer types and ages at diagnosis, if known.
- Bring previous genetic test reports or relevant pathology reports, if available.
- Fasting is not required.
After the Service
- Schedule a follow-up appointment to receive and discuss the results within the timeframe advised by the hospital.
- If a clinically significant genetic variant is identified, discuss appropriate follow-up and family risk assessment with your physician.
Terms and Conditions
- Health check-up services are available at the Advanced Diagnostic Centre, 4th floor in Zone A, BNH Hospital on Monday-Sunday from 7 am. – 4 pm.
- All packages are inclusive of doctor’s fee, medical supplies, and hospital and nursing services fee.
- Please make an appointment at the Advanced Diagnostic Centre via LINE @Mbrace or E-mail: [email protected] or call 02-022-0847, 02-022-0700 ext. 4445–4447 (calls during 1–3 pm. only)
- Appointment confirmation will be made via e-mail or phone call during 1–3 pm.
- In case the change of appointment date is required, please notify at least 2 days in advance.
- All packages are transferable.
- Expenses for additional consultation, investigation, or treatment other than the package are not included.
- Services are available during Now to 31st December, 2027
- For more information, please contact the Advanced Diagnostic Centre, BNH Hospital at 02-022-0700 ext. 4445, 4447
- Appointment required: 5–7 days in advance.
Frequently Asked Questions (FAQ) about Hereditary Cancer Panel (Standard)
A: It includes the Encode Hereditary Multi-Cancer Panel, which covers 90 genes in the standard test panel, together with the doctor’s fee, nursing and hospital services fee.
A: It is suitable for both men and women, particularly those with a personal or family history of cancer, multiple relatives affected by cancer, cancer diagnosed at an unusually young age in the family, or a suspected hereditary cancer syndrome.
A: Results may show a pathogenic or likely pathogenic variant, no clinically significant variant, or a variant of uncertain significance (VUS). A result with no significant variant does not eliminate cancer risk, and a VUS requires medical interpretation.
A: They can help assess inherited cancer risk, support personalized screening and follow-up planning, and may guide genetic counseling for family members when appropriate. It can be purchased on M BRACE or at BNH Hospital, and the hospital team can advise on appointments and next steps.
ไทย
简体中文



